United States · Who invested in Merganser Biotech?
Merganser Biotech's investors include Sutter Hill Ventures, Novartis Venture Fund, Frazier Healthcare Partners, Osage University Partners and BioAdvance.
United States · Series A startup
Who invested in Merganser Biotech
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Merganser Biotech and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$28Mraised across 1 round since 2015, from 1 source
- Latest round
- Series A, $28MFeb 2015
- Investors
- 5
The rounds
- Feb 2015Series A$28M
Sutter Hill Ventures
Novartis Venture Fund
Frazier Healthcare Partners
Osage University Partners
BioAdvance
From a historical funding recordSEC filing: $8.0M sold, first sale Feb 2015
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Merganser Biotech
How much has Merganser Biotech raised?
Merganser Biotech has raised $28M across 1 round since 2015.
When did Merganser Biotech last raise?
Merganser Biotech's most recent round was a Series A of $28M in Feb 2015.
What was Merganser Biotech's biggest round?
Its most recent round, $28M in Feb 2015, is also its largest on record.
Who backed Merganser Biotech first?
Merganser Biotech's first round on record, in Feb 2015, was backed by Sutter Hill Ventures, Novartis Venture Fund and Frazier Healthcare Partners and 2 others.
What stage is Merganser Biotech at?
Merganser Biotech's latest named round is a Series A, in Feb 2015.
Where is Merganser Biotech based?
Merganser Biotech is based in the United States.
Companies like Merganser Biotech
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.